Aim Smart

AimSmart is an AI-powered biotechnology company specializing in the discovery of small molecule therapeutics for traditionally "undruggable" targets, with a primary focus on protein-protein interactions (PPIs). The company integrates advanced artificial intelligence with structural biology and molecular dynamics to model complex protein conformations and binding sites. By leveraging deep learning algorithms, AimSmart aims to accelerate the identification and optimization of high-affinity lead compounds for oncology and immunological disorders. Headquartered in Suzhou, China, the firm bridges the gap between computational prediction and experimental validation to address unmet medical needs. Their platform is designed to unlock therapeutic opportunities in pathways that have remained elusive to conventional drug discovery methods.